UPDATE: Silence Therapeutics CEO Solomon Resigns Amid Court Action
UPDATE: Silence Therapeutics CEO Solomon Resigns Amid Court Action
Read moreUPDATE: Silence Therapeutics CEO Solomon Resigns Amid Court Action
Read moreSilence Therapeutics Chair To Become Executive; CEO Faces Court Action
Read more(Sharecast News) - Silence Therapeutics announced a "strengthening" of its board and management team on Tuesday, with Iain Ross set to be appointed as executive chairman from 1 January.
Read more* European shares dip ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* Wall Street treads water* Tullow Oil slumps 71% as CEO quits, co scraps dividend Welcome to the home for real-time coverage of Eu...
Read more* European shares dip ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* Wall Street treads water* Tullow Oil slumps 60% as CEO quits, co scraps dividend Welcome to the home for real-time coverage of Eu...
Read more* European shares dip ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* European bourses down between 0.1% and 1%* Wall Street opens in the black* Tullow Oil slumps 60% as CEO quits, co scraps dividend ...
Read more* European shares dip ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* European bourses down between 0.1% and 1%* Wall Street futures in the red* Tullow Oil slumps 60% as CEO quits, co scraps dividend ...
Read more* European shares dip ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* STOXX 600, DAX and FTSE 100 down 0.1%* Tullow Oil slumps 60% as CEO quits, co scraps dividend Welcome to the home for real-time c...
Read more* European shares little changed ahead of big events this week* Investors await for Fed and ECB meetings, UK vote, trade deadline* STOXX 600 and DAX flat, FTSE 100 down 0.1%* Tullow Oil down nearly 60% as CEO quits, co scraps dividend Welcome to the...
Read moreInvestor Quested Lifts Stake In Silence Therapeutics To 11%
Read moreFirst USD2 Million Milestone Hit In Silence Therapeutics Collaboration
Read more(Alliance News) - Genetic medicines developer Silence Therapeutics PLC said Wednesday its interim loss remained broadly stable during the "transformational" period in which it signed a -
Read more(Sharecast News) - Silence Therapeutics said on Thursday that the first half of the year saw good progress in the development of its lead candidate, SLN124, with the first patient set to be dosed before the year is out.
Read moreFriday 6 September SIGHalf Year ResultsAshmore GroupFull Year Public Year Horizon Year 9
Read more(Alliance News) - Silence Therapeutics PLC said Monday that it has appointed Jorgen Wittendorff to the new role of head of manufacturing.Wittendorff will be joining the company's senior
Read more